Identification of a small-molecule targeting PLAGL2 DNA-binding domain inhibits extracellular matrix formation and enhances lenvatinib sensitivity in hepatocellular carcinoma
鉴定出一种靶向PLAGL2 DNA结合域的小分子，该小分子可抑制细胞外基质形成并增强肝细胞癌对乐伐替尼的敏感性。
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.12.016
Hu, Weiwei; Ni, Jiaping; Zheng, Shufang; Wei, Xiaohui; Zhai, Dongqing; Qi, Jinglin; Ye, Xinqi; Lu, Mingyin; Bian, Hanrui; Li, Jintong; Shen, Yumeng; Jiang, Jingwei; Zhao, Weijun; Shao, Xueqing; Xu, Shihao; Liang, Xuewu; Liu, Hong; Yang, Yong
